{"name":"Vedic Lifesciences Pvt. Ltd.","slug":"vedic-lifesciences-pvt-ltd","ticker":"","exchange":"","domain":"vediclifesciencespvt.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"A. Chilensis","genericName":"A. Chilensis","slug":"a-chilensis","indication":"Other","status":"phase_3"},{"name":"Lactobacillus Species","genericName":"Lactobacillus Species","slug":"lactobacillus-species","indication":"Digestive health and gut microbiome support","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"A. Paniculata","genericName":"A. Paniculata","slug":"a-paniculata","indication":"Respiratory tract infections and common cold (Phase 3)","status":"phase_3"},{"name":"A. Paniculata and A. Chilensis","genericName":"A. Paniculata and A. Chilensis","slug":"a-paniculata-and-a-chilensis","indication":"Immune support and inflammatory conditions (Phase 3 indication not publicly specified)","status":"phase_3"}]}],"pipeline":[{"name":"A. Chilensis","genericName":"A. Chilensis","slug":"a-chilensis","phase":"phase_3","mechanism":"A. Chilensis is a botanical extract with potential immunomodulatory and antioxidant properties.","indications":[],"catalyst":""},{"name":"A. Paniculata","genericName":"A. Paniculata","slug":"a-paniculata","phase":"phase_3","mechanism":"Andrographis paniculata extract enhances immune function and reduces inflammatory markers through multiple phytochemical constituents.","indications":["Respiratory tract infections and common cold (Phase 3)","Immune support and inflammation modulation"],"catalyst":""},{"name":"A. Paniculata and A. Chilensis","genericName":"A. Paniculata and A. Chilensis","slug":"a-paniculata-and-a-chilensis","phase":"phase_3","mechanism":"A herbal combination derived from Andrographis paniculata and Andrographis chilensis that modulates immune function and reduces inflammation through multiple phytochemical constituents.","indications":["Immune support and inflammatory conditions (Phase 3 indication not publicly specified)"],"catalyst":""},{"name":"Lactobacillus Species","genericName":"Lactobacillus Species","slug":"lactobacillus-species","phase":"marketed","mechanism":"Lactobacillus species are live beneficial bacteria that colonize the gut microbiome and promote digestive health and immune function.","indications":["Digestive health and gut microbiome support","Gastrointestinal disorders and dysbiosis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}